Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9888512rdf:typepubmed:Citationlld:pubmed
pubmed-article:9888512lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9888512lifeskim:mentionsumls-concept:C0171961lld:lifeskim
pubmed-article:9888512lifeskim:mentionsumls-concept:C2698421lld:lifeskim
pubmed-article:9888512lifeskim:mentionsumls-concept:C0056371lld:lifeskim
pubmed-article:9888512lifeskim:mentionsumls-concept:C1417838lld:lifeskim
pubmed-article:9888512lifeskim:mentionsumls-concept:C1158770lld:lifeskim
pubmed-article:9888512lifeskim:mentionsumls-concept:C1335671lld:lifeskim
pubmed-article:9888512pubmed:issue3-4lld:pubmed
pubmed-article:9888512pubmed:dateCreated1999-4-13lld:pubmed
pubmed-article:9888512pubmed:abstractTextThe adrenocorticotropin receptor or ACTH-R which is the type 2 among the melanocortin receptor family is almost exclusively expressed in the adrenal cortex, reflecting a high degree of tissue specificity. In human cultured adrenocortical cells, we have previously reported that ACTH in contrast to most of the peptide hormones, is able to up-regulate the number of its own receptors through an increase of the transcriptional activity of the encoding gene. Three putative SF-1 binding sites are present in the sequence of the human ACTH-R gene promoter at -35 (SF-35), -98 (SF-98) and -209 (SF-209). By EMSA studies, we demonstrated that these sites effectively bind SF-1 protein. After transient transfection of H295R cells using a construct containing the first 263 bp upstream of the transcriptional start site, in front of the luciferase gene in the pGL3 vector, we demonstrated the involvement of all three SF-1 sites to confer maximal constitutive activity to a proximal region of the hACTH-R gene promoter. Only SF-35 and SF-98 play a role in cAMP-induced regulation of this gene.lld:pubmed
pubmed-article:9888512pubmed:languageenglld:pubmed
pubmed-article:9888512pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:citationSubsetIMlld:pubmed
pubmed-article:9888512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9888512pubmed:statusMEDLINElld:pubmed
pubmed-article:9888512pubmed:issn0743-5800lld:pubmed
pubmed-article:9888512pubmed:authorpubmed-author:DurandPPlld:pubmed
pubmed-article:9888512pubmed:authorpubmed-author:BégeotMMlld:pubmed
pubmed-article:9888512pubmed:authorpubmed-author:MarchalRRlld:pubmed
pubmed-article:9888512pubmed:authorpubmed-author:PenhoatAAlld:pubmed
pubmed-article:9888512pubmed:authorpubmed-author:NavilleDDlld:pubmed
pubmed-article:9888512pubmed:issnTypePrintlld:pubmed
pubmed-article:9888512pubmed:volume24lld:pubmed
pubmed-article:9888512pubmed:ownerNLMlld:pubmed
pubmed-article:9888512pubmed:authorsCompleteYlld:pubmed
pubmed-article:9888512pubmed:pagination391-5lld:pubmed
pubmed-article:9888512pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:meshHeadingpubmed-meshheading:9888512-...lld:pubmed
pubmed-article:9888512pubmed:articleTitleSF-1 and the transcriptional regulation of the human ACTH receptor gene.lld:pubmed
pubmed-article:9888512pubmed:affiliationINSERM-INRA U418 and Université Claude Bernard, Hôpital Debrousse, Lyon, France.lld:pubmed
pubmed-article:9888512pubmed:publicationTypeJournal Articlelld:pubmed